Gastrointestinal bleeding risk with rivaroxaban vs aspirin in atrial fibrillation: A multinational study.
Laura FanningIan Chi Kei Ck WongXue LiEsther Wai Yin ChanPajaree MongkhonKenneth Keng Cheung ManLi WeiWai K LeungPeteris DarzinsJ Simon BellJenni S IlomakiWallis C Y LauPublished in: Pharmacoepidemiology and drug safety (2020)
In patients with AF, GIB risk was comparable between aspirin and rivaroxaban ≤15 mg/day. GIB risk for rivaroxaban 20 mg/day vs aspirin remains uncertain and warrants further investigation.